Standard Biotools (LAB) Capital Expenditures (2010 - 2026)

Standard Biotools (LAB) has 17 years of Capital Expenditures data on file, last reported at $319000.0 in Q1 2026.

• On a quarterly basis, Capital Expenditures fell 93.69% year-over-year to $319000.0 in Q1 2026; TTM through Mar 2026 was -$3.9 million, a 163.81% decrease from a year earlier, with the FY2025 full-year figure at $851000.0, down 53.09% from the prior year.
• Capital Expenditures for Q1 2026 stood at $319000.0, down from $716000.0 in the prior quarter.
• Over the last five years, Capital Expenditures for LAB reached as high as $5.1 million in Q1 2025 and fell as low as -$4.9 million in Q2 2025.
• Historically, Capital Expenditures has averaged $400529.4 across 5 years, with a median of $781000.0 in 2024.
• On a YoY basis, Capital Expenditures climbed as much as 547.12% in 2025 and fell as far as 523.69% in 2025.
• Year by year, Capital Expenditures stood at $755000.0 in 2022, then plunged by 464.64% to -$2.8 million in 2023, then declined by 14.75% to -$3.2 million in 2024, then surged by 122.67% to $716000.0 in 2025, then tumbled by 55.45% to $319000.0 in 2026.
• Per Business Quant data, the three most recent Capital Expenditures figures were $319000.0 in Q1 2026, $716000.0 in Q4 2025, and -$48000.0 in Q3 2025.